SAE1
Basic information
Region (hg38): 19:47113273-47210636
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (7 variants)
- not provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SAE1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 8 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 0 | |||||
non coding ? | 1 | |||||
Total | 0 | 0 | 7 | 2 | 1 |
Variants in SAE1
This is a list of pathogenic ClinVar variants found in the SAE1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-47130961-A-G | not specified | Uncertain significance (Aug 18, 2023) | ||
19-47131010-G-A | not specified | Uncertain significance (Mar 21, 2022) | ||
19-47143522-G-A | Likely benign (Apr 01, 2022) | |||
19-47143562-T-G | not specified | Uncertain significance (Oct 03, 2023) | ||
19-47150242-C-A | not specified | Uncertain significance (Sep 17, 2021) | ||
19-47150257-G-A | not specified | Uncertain significance (Mar 22, 2023) | ||
19-47150262-A-G | not specified | Uncertain significance (Mar 01, 2024) | ||
19-47150323-A-G | not specified | Uncertain significance (Dec 13, 2023) | ||
19-47150340-A-G | not specified | Uncertain significance (Nov 08, 2022) | ||
19-47197285-T-C | Benign (Dec 31, 2019) | |||
19-47197298-G-C | not specified | Uncertain significance (Jan 08, 2024) | ||
19-47203687-A-G | not specified | Uncertain significance (Feb 14, 2024) | ||
19-47203732-A-G | not specified | Uncertain significance (Dec 08, 2023) | ||
19-47209190-A-G | not specified | Uncertain significance (Aug 02, 2021) | ||
19-47209207-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
19-47209278-G-A | Likely benign (Apr 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SAE1 | protein_coding | protein_coding | ENST00000270225 | 9 | 97356 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.988 | 0.0124 | 125735 | 0 | 11 | 125746 | 0.0000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.563 | 170 | 192 | 0.886 | 0.0000101 | 2267 |
Missense in Polyphen | 38 | 56.538 | 0.67212 | 687 | ||
Synonymous | -0.478 | 77 | 71.8 | 1.07 | 0.00000397 | 664 |
Loss of Function | 3.67 | 1 | 17.7 | 0.0566 | 9.29e-7 | 215 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000333 | 0.0000333 |
Ashkenazi Jewish | 0.000198 | 0.000198 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000880 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: The heterodimer acts as an E1 ligase for SUMO1, SUMO2, SUMO3, and probably SUMO4. It mediates ATP-dependent activation of SUMO proteins followed by formation of a thioester bond between a SUMO protein and a conserved active site cysteine residue on UBA2/SAE2. {ECO:0000269|PubMed:10187858, ECO:0000269|PubMed:10217437, ECO:0000269|PubMed:11451954, ECO:0000269|PubMed:11481243, ECO:0000269|PubMed:15660128, ECO:0000269|PubMed:20164921, ECO:0000269|PubMed:9920803}.;
- Pathway
- Ubiquitin mediated proteolysis - Homo sapiens (human);er associated degradation (erad) pathway;SUMO is conjugated to E1 (UBA2:SAE1);SUMO is transferred from E1 to E2 (UBE2I, UBC9);Post-translational protein modification;basic mechanisms of sumoylation;Metabolism of proteins;Processing and activation of SUMO;SUMOylation
(Consensus)
Recessive Scores
- pRec
- 0.125
Intolerance Scores
- loftool
- 0.449
- rvis_EVS
- -0.38
- rvis_percentile_EVS
- 27.88
Haploinsufficiency Scores
- pHI
- 0.632
- hipred
- Y
- hipred_score
- 0.831
- ghis
- 0.662
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.997
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sae1
- Phenotype
Zebrafish Information Network
- Gene name
- sae1
- Affected structure
- hematopoietic multipotent progenitor cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- protein ubiquitination;protein sumoylation;protein modification by small protein conjugation;positive regulation of catalytic activity;positive regulation of protein targeting to mitochondrion
- Cellular component
- nucleus;nucleoplasm;cytoplasm;SUMO activating enzyme complex
- Molecular function
- ubiquitin activating enzyme activity;protein binding;protein C-terminus binding;enzyme activator activity;SUMO activating enzyme activity;ATP-dependent protein binding;small protein activating enzyme binding;protein heterodimerization activity